Pharma Mar, S.A. (BME:PHM)
78.00
-5.95 (-7.09%)
At close: Mar 3, 2026
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.34 billion as of March 3, 2026. Its market cap has decreased by -21.47% in one year.
Market Cap
1.34B
Enterprise Value
1.25B
Revenue
179.28M
Ranking
n/a
PE Ratio
39.99
Stock Price
€78.00
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.34B, a decrease of -25.39%. That is a compound annual growth rate of -2.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.47B |
| Laboratorios Farmaceuticos Rovi | 4.33B |
| Almirall | 2.77B |
| Faes Farma | 1.62B |
| Clínica Baviera | 835.83M |
| Oryzon Genomics | 247.60M |
| Prim, S.A. | 232.27M |
| Atrys Health | 224.59M |